Respiratory Syncytial Virus Vaccine Clinical Trial

Last updated: May 26, 2023
Sponsor: GSK
Overall Status: Active - Recruiting

Phase

N/A

Condition

Vaccines

Respiratory Syncytial Virus (Rsv)

Respiratory Syncytial Virus (Rsv) Infection

Treatment

N/A

Clinical Study ID

TX312837
  • Ages 60-100
  • All Genders

Study Summary

We are seeking adult participants, 60 years of age or older for a Respiratory Syncytial Virus (RSV) vaccine clinical research trial. This study is evaluating the immune response of an investigational RSV vaccine co- administered with a Pneumococcal Conjugate Vaccine.

Study Design

Study Start date:
May 23, 2023
Estimated Completion Date:

Study Description

  • Reimbursement available up to $100 per visit & $51 for travel to on-site visits only
  • You are provided study-related care and study vaccine at no cost (no health insurance required)
  • You may help make a difference for yourself and for individuals like you

Connect with a study center

  • Chase Medical Research, LLC

    Hamden, Connecticut 06517
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.